Atlas Trials

An Open-Label Study of the Safety and Pharmacokinetics of Repeated-Dose Micafungin in Neonates

Clinical trial NCT00818584 · COMPLETED

Trial details

NCT number
NCT00818584
Sponsor
Astellas Pharma Inc
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Candida
Start date
2007-08-01
Primary completion
2007-10-01
Enrollment
13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.